BIOHAVEN LTD BHVN

US Healthcare Pharmaceutical Preparations
$15.96
+1.3%
52w: $7.79 – $18.11

Latest 13F among current holders filed 11 days ago (Jun 24, 2026)

Price — last 12 months

research preview data
7.7912.9518.11
Jun 20, 2025 Jul 2, 2026
Institutional holders
275
+3 QoQ
13F value
$1.22B
-11.4% QoQ
Smart-money holders
24
signal tier ≥ 2
New smart buyers
3
Q1 2026
Options barometer
3.9×
$20.3M calls / $5.1M puts

Institutional value by quarter

$4.40B
Q1 2024
$2.90B
Q2 2024
$4.36B
Q3 2024
$3.48B
Q4 2024
$2.24B
Q1 2025
$1.23B
Q2 2025
$1.29B
Q3 2025
$1.37B
Q4 2025
$1.22B
Q1 2026

Number of holders

245
Q1 2024
227
Q2 2024
257
Q3 2024
258
Q4 2024
267
Q1 2025
250
Q2 2025
264
Q3 2025
272
Q4 2025
275
Q1 2026

Who owns BHVN?

Q1 2026 filings
FundTypeSharesValue% of fundChange
JANUS HENDERSON GROUP PLC Diversified mechanical17.5M$148.2M0.1%+1145.9%
BlackRock, Inc. Index provider11.2M$94.9M0.0%+18.8%
SUVRETTA CAPITAL MANAGEMENT, LLC ★2Fundamental diversified10.3M$87.0M2.4%Held
STIFEL FINANCIAL CORP Diversified mechanical9.9M$84.1M0.1%0.0%
STATE STREET CORP Index provider6.6M$56.0M0.0%+15.8%
INFINITUM ASSET MANAGEMENT, LLC ★3Fundamental concentrated6.3M$52.9M6.6%Held
TCG Crossover Management, LLC ★3Fundamental concentrated4.6M$39.2M1.1%Held
STEMPOINT CAPITAL LP ★2Fundamental concentrated3.2M$27.0M2.6%New
Royalty Pharma Sub-Manager, LLC ★2Fundamental diversified2.9M$24.8M14.4%Held
D. E. Shaw & Co., Inc. Quant stat arb2.8M$24.1M0.0%+5.7%
GEODE CAPITAL MANAGEMENT, LLC Index provider2.8M$23.4M0.0%+15.7%
GOLDMAN SACHS GROUP INC Bank broker2.5M$21.3M0.0%+28.1%
Balyasny Asset Management L.P. Multistrat pod2.4M$20.7M0.0%+53.7%
FMR LLC Long only active2.4M$20.0M0.0%-12.0%
VANGUARD PORTFOLIO MANAGEMENT LLC Diversified mechanical2.3M$19.3M0.0%
PRICE T ROWE ASSOCIATES INC /MD/ Diversified mechanical2.2M$18.8M0.0%+9.8%
AQR CAPITAL MANAGEMENT LLC Quant stat arb2.0M$16.7M0.0%+35.3%
Cormorant Asset Management, LP ★3Fundamental concentrated1.8M$14.9M0.8%+17500.0%
CITADEL ADVISORS LLC Multistrat pod1.7M$14.6M0.0%-1.2%
BNP PARIBAS FINANCIAL MARKETS Bank broker1.5M$13.1M0.0%-26.2%
Qube Research & Technologies Ltd Quant stat arb1.5M$13.0M0.0%-1.9%
ExodusPoint Capital Management, LP Multistrat pod1.5M$12.7M0.1%+25.9%
ADAGE CAPITAL PARTNERS GP, L.L.C. Other1.5M$12.7M0.0%+898.5%
MILLENNIUM MANAGEMENT LLC Multistrat pod1.4M$12.2M0.0%+9.3%
UBS Group AG Bank broker1.4M$12.1M0.0%+20.0%
ARS Investment Partners, LLC ★2Fundamental diversified1.4M$11.7M0.6%+11.2%
Capital Research Global Investors Long only active1.3M$11.3M0.0%Held
VANGUARD CAPITAL MANAGEMENT LLC Diversified mechanical1.3M$10.7M0.0%
MYDA Advisors LLC Quant stat arb1.2M$10.4M2.4%-2.0%
VOLORIDGE INVESTMENT MANAGEMENT, LLC Diversified mechanical1.2M$10.3M0.0%-7.5%
TWO SIGMA INVESTMENTS, LP Quant stat arb1.2M$10.0M0.0%-5.7%
Sio Capital Management, LLC ★2Fundamental concentrated1.2M$9.8M1.4%-6.5%
MORGAN STANLEY Bank broker1.0M$8.7M0.0%+5.3%
NORTHERN TRUST CORP Index provider1.0M$8.5M0.0%+19.2%
Integral Health Asset Management, LLC ★2Fundamental diversified1.0M$8.5M0.4%-33.3%
CHARLES SCHWAB INVESTMENT MANAGEMENT INC Index provider941.1K$8.0M0.0%+11.1%
Simplify Asset Management Inc. Wealth advisor898.4K$7.6M0.1%-6.2%
Trexquant Investment LP Diversified mechanical877.8K$7.4M0.1%+45.3%
DAFNA Capital Management LLC ★2Fundamental diversified845.7K$7.2M1.6%-11.5%
HRT FINANCIAL LP Diversified mechanical833.7K$7.1M0.0%+24.6%
Fiera Capital Corp Other774.2K$6.5M0.0%+6.8%
Aberdeen Group plc Other771.5K$6.5M0.0%+11.2%
BANK OF AMERICA CORP /DE/ Bank broker759.4K$6.4M0.0%-57.6%
Nuveen, LLC Diversified mechanical745.7K$6.3M0.0%+1.9%
5AM Venture Management, LLC ★3Fundamental concentrated739.0K$6.3M1.7%Held
Kynam Capital Management, LP ★3Fundamental concentrated702.9K$5.9M0.4%Held
VANGUARD FIDUCIARY TRUST CO Diversified mechanical701.6K$5.9M0.0%
Erste Asset Management GmbH Other693.3K$5.6M0.1%Held
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC Bank broker618.2K$5.2M0.0%+7.6%
SPHERA FUNDS MANAGEMENT LTD. Other594.0K$5.0M0.9%New

Exits are not a bearish signal: our backtest shows stocks specialists exit keep outperforming for 3+ quarters — selling usually means profit-taking, not a forecast.